Academic Pathologist & HLA Laboratory Director

Beth Israel Deaconess Medical Center (BIDMC); Boston (MA); On-site; USD 269,000 - 321,000; Full time

Job summary

Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA, seeks a full-time Staff Pathologist, HLA Director, for its Histocompatibility and Immunogenetics Laboratory. Role includes leadership of a growing program and teaching responsibilities within a Harvard-affiliated system.

Ideal candidates hold MD or PhD with ACHI/ASHI credentials and are prepared to oversee state-of-the-art testing, translational research, and collaboration across transplantation services.

Qualifications

• MD or PhD with board certification or eligibility in histocompatibility and immunogenetics.
• ASHI credentialing as HLA Laboratory Director.
• Valid MA medical license or ability to obtain one.
• Experience in high-resolution HLA typing, antibody screening, engraftment monitoring, and crossmatch testing.
• Expertise in next-generation sequencing and laboratory informatics is highly desirable.
• Willingness to contribute to teaching and translational/clinical research.

Responsibilities

• Oversee a growing histocompatibility and immunogenetics laboratory.
• Support clinical programs in solid organ and hematopoietic stem cell transplantation.
• Contribute to pathology training programs and develop translational research.

Skills

Histocompatibility and Immunogenetics

High-resolution HLA typing

HLA antibody screening

Engraftment monitoring

Crossmatch testing

Laboratory informatics

NGS

Leadership in lab

Education

MD from an accredited medical school

PhD from an accredited school

Job description

Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA, seeks a full-time Staff Pathologist, HLA Director, for its Histocompatibility and Immunogenetics Laboratory. Role includes leadership of a growing program and teaching responsibilities within a Harvard-affiliated system.

Ideal candidates hold MD or PhD with ACHI/ASHI credentials and are prepared to oversee state-of-the-art testing, translational research, and collaboration across transplantation services.